Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05889650Not ApplicableRecruiting

External Lumbar Drainage to Reduce ICP in Severe TBI: a Phase 1 Clinical Trial

Role: lead

NCT02877732Not ApplicableTerminated

EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 2

Role: collaborator

NCT02844543Not ApplicableCompleted

EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 1

Role: collaborator

NCT00743821Completed

Eye-Tracking Rapid Attention Computation

Role: lead

All 4 trials loaded